![Christy Marshuetz Ferguson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Christy Marshuetz Ferguson worked as a Vice President of Business Development at GeneCentric Therapeutics, Inc. She received an undergraduate degree from the University of Michigan, a doctorate degree from the University of Michigan in 2000, and an MBA from Kenan-Flagler Business School in 2008.
Former positions of Christy Marshuetz Ferguson
Companies | Position | End |
---|---|---|
GeneCentric Therapeutics, Inc.
![]() GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Training of Christy Marshuetz Ferguson
University of Michigan | Undergraduate Degree |
Kenan-Flagler Business School | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
GeneCentric Therapeutics, Inc.
![]() GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Christy Marshuetz Ferguson